EUR 21.7
(-0.46%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 14.5 Million EUR | -54.62% |
2022 | 9.85 Million EUR | 14.08% |
2021 | 8.63 Million EUR | 21.99% |
2020 | 7.08 Million EUR | 851.88% |
2019 | 744 Thousand EUR | 115.65% |
2018 | 345 Thousand EUR | 41.98% |
2017 | 243 Thousand EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 Q2 | 3.15 Million EUR | 0.0% |
2023 Q3 | 3.51 Million EUR | 11.32% |
2023 Q1 | 3.15 Million EUR | -10.16% |
2023 FY | 4.47 Million EUR | -54.62% |
2023 Q4 | 3.51 Million EUR | 0.0% |
2022 Q4 | 3.51 Million EUR | 0.0% |
2022 FY | 9.85 Million EUR | 14.08% |
2022 Q3 | 3.51 Million EUR | 85.42% |
2022 Q2 | 1.89 Million EUR | -64.54% |
2022 Q1 | 5.34 Million EUR | 221.11% |
2021 Q1 | 2.34 Million EUR | 403.33% |
2021 FY | 8.63 Million EUR | 21.99% |
2021 Q4 | 1.66 Million EUR | -25.87% |
2021 Q3 | 2.24 Million EUR | 66.37% |
2021 Q2 | 1.35 Million EUR | -42.32% |
2020 Q1 | 2.91 Million EUR | 1333.5% |
2020 FY | 7.08 Million EUR | 851.88% |
2020 Q4 | 465 Thousand EUR | 0.0% |
2020 Q2 | 2.91 Million EUR | 0.0% |
2019 Q4 | 202.99 Thousand EUR | 0.0% |
2019 FY | 744 Thousand EUR | 115.65% |
2018 FY | 345 Thousand EUR | 41.98% |
2017 FY | 243 Thousand EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
ARTERRA BIOSCIENCE | 3.38 Million EUR | -328.735% |
Ulisse Biomed S.p.A. | 1.91 Million EUR | -659.621% |